Lipid Screening and Cardiovascular Health in Childhood

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pediatrics

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2008-1349PMID 18596007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement

  2007cited by this paper
• Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.

  2007cited by this paper
• Prevalence of overweight and obesity in the United States, 1999-2004.

  2006cited by this paper
• Development of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP study

  2006cited by this paper
• Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee

  2006cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• What the statin trials have taught us.

  2006cited by this paper
• Trans fatty acids and coronary heart disease.

  2006cited by this paper
• Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study

  2006cited by this paper
• Active Healthy Living: Prevention of Childhood Obesity Through Increased Physical Activity

  2006cited by this paper
• Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

  2005cited by this paper
• The relationship of health outcomes to improvement in BMI in children and adolescents.

  2005cited by this paper
• Evidence based physical activity for school-age youth.

  2005cited by this paper
• Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association.

  2005cited by this paper
• The global spread of type 2 diabetes mellitus in children and adolescents.

  2005cited by this paper
• Obesity and the metabolic syndrome in children and adolescents.

  2004cited by this paper
• Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

  2004cited by this paper
• The metabolic syndrome in children and adolescents

  2004cited by this paper
• Cardiovascular risk factors in childhood and carotid intima-media thickness in adulthood. The cardiovascular risk in young finns study

  2004cited by this paper
• Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands

  2004cited by this paper
• Trends in Risk Factors for Cardiovascular Disease Among Children and Adolescents in the United States

  2004cited by this paper
• Cholesterol screening in children: insights from Project HeartBeat! and NHANES III

  2003cited by this paper
• Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.

  2003cited by this paper
• American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood.

  2003cited by this paper
• Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.

  2003cited by this paper
• Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

  2003cited by this paper
• American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin

  2002cited by this paper
• A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia

  2002cited by this paper
• Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: the STRIP study. Special Turku Coronary Risk Factor Intervention Project.

  2002cited by this paper
• Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

  2002cited by this paper
• Primary prevention of high blood cholesterol concentrations in the United States.

  2002cited by this paper
• Stanol/Sterol Ester–Containing Foods and Blood Cholesterol Levels A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association

  2001cited by this paper
• Effects of Nonlipid Risk Factors on Atherosclerosis in Youth With a Favorable Lipoprotein Profile

  2001cited by this paper
• AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association.

  2001cited by this paper
• Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study

  2001cited by this paper
• Trans fatty acids and coronary heart disease.

  1999cited by this paper
• Serum cholesterol ester fatty acids in 7‐ and 13‐month‐old children in a prospective randomized trial of a low‐saturated fat, low‐cholesterol diet: the STRIP baby project

  1999cited by this paper
• Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.

  1999cited by this paper
• Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project. Special Turku coronary Risk factor Intervention Project for children.

  1999cited by this paper
• Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

  1998cited by this paper
• Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

  1998cited by this paper
• American Academy of Pediatrics. Committee on Nutrition. Cholesterol in childhood.

  1998cited by this paper
• Determinants of atherosclerosis in the young

  1998cited by this paper
• Cholesterol in Childhood

  1998cited by this paper
• Prevalence of high cholesterol, high blood pressure, and smoking among elementary schoolchildren in North Carolina.

  1997cited by this paper
• Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.

  1997cited by this paper
• Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial.

  1997cited by this paper
• Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia

  1996cited by this paper
• Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.

  1996cited by this paper
• Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.

  1996cited by this paper
• Failure of current guidelines for cholesterol screening in urban African-American adolescents.

  1996cited by this paper
• Considerations about dietary fat restrictions for children.

  1996cited by this paper
• Cardiovascular risk factors among third grade children in four regions of the United States. The CATCH Study. Child and Adolescent Trial for Cardiovascular Health.

  1995cited by this paper
• Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.

  1995cited by this paper
• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1995cited by this paper
• Cardiovascular Risk Factors among Third Grade Children in Four Regions of the United States: The CATCH Study

  1995cited by this paper
• Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: The dietary intervention study in children (DISC)

  1995cited by this paper
• Challenges to implementing the current pediatric cholesterol screening guidelines into practice.

  1994cited by this paper
• Niacin treatment of hypercholesterolemia in children.

  1993cited by this paper
• Compliance with childhood cholesterol screening among members of a prepaid health plan.

  1993cited by this paper
• Prevention of familial cardiovascular disease by screening for family history and lipids in youths.

  1992cited by this paper
• National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

  1992cited by this paper
• Seasonal variation in plasma cholesterol distributions: implications for screening and referral.

  1992cited by this paper
• Simvastatin use in children.

  1992cited by this paper
• The Bogalusa Heart Study

  1991cited by this paper
• Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study.

  1991cited by this paper
• Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study.

  1990cited by this paper
• Family history evaluation as a predictive screen for childhood hypercholesterolemia. The Pediatric Practice Research Group.

  1989cited by this paper
• Family History Evaluation as a Predictive Screen for Childhood Hypercholesterolemia

  1989cited by this paper
• Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study.

  1988cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study

  1986cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

  1986cited by this paper
• Sick individuals and sick populations.

  1985cited by this paper
• THE PHARMACOLOGICAL BASIS OF THERAPEUTICS

  1981cited by this paper
• Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study.

  1981cited by this paper
• Treatment of familial hypercholesterolemia in children.

  1971cited by this paper

• Post-Acute Dyslipidemia and Abnormal BMI in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative.

  2026cites this paper
• Diagnosis of Familial Hypercholesterolemia in Children: From Clinical Features Through Gene Variants to Polygenic Score

  2026cites this paper
• Long-term endocrine and testicular outcomes in male survivors of childhood acute lymphoblastic leukemia.

  2026cites this paper
• Effects of different exercise modalities on lipid profiles in overweight and obese children and adolescents: a systematic review and network meta-analysis of randomized controlled trials.

  2026cites this paper
• Long-Term endocrine outcomes with special emphasis on the gonadal impact of acute lymphoblastic leukemia treatment in females

  2026cites this paper
• Differences in the effects of HIIT versus aerobic training on intervening in dyslipidemia in children and adolescents: A systematic review and meta-analysis.

  2026cites this paper
• The Role of Non-HDL Cholesterol and Apolipoprotein B in Cardiovascular Disease: A Comprehensive Review

  2025cites this paper
• New era, new GOALs: cardiovascular screening and lipid management in cystic fibrosis

  2025cites this paper
• Dyslipidaemia among children and adolescents in Pakistan: a five-year retrospective cohort study based on laboratory data

  2025cites this paper
• Usefulness of Non-High-Density Lipoprotein Cholesterol for Screening Dyslipidemia in Children and Adolescents with Overweight or Obesity: A Single-Center Retrospective Study

  2025cites this paper
• The lysosomal acid lipase deficiency spectrum from infancy to adulthood: a multidisciplinary experience.

  2025cites this paper
• Non-HDL Cholesterol in Dyslipidemia Screening Among Korean Adolescents: A National Population-Based Survey

  2025cites this paper
• Post-acute dyslipidemia and abnormal BMI in children and adolescents with COVID-19: An EHR Cohort Study from the RECOVER Initiative

  2025cites this paper
• Role of Serotonin, Membrane Transporter, and 5-HT2 Receptors in Pathogenesis of Atherosclerotic Plaque Formation in Immature Heterozygous Low-Density Lipoprotein-Receptor-Deficient Mice

  2025cites this paper
• Developing a Knowledge Translation Intervention to Improve the Detection and Management of Pediatric Dyslipidemias in British Columbia

  2025cites this paper
• Association of Serum Uric Acid Levels with Cardiometabolic Factors in Adolescents with Obesity: A Cross-Sectional Study

  2025cites this paper
• Application of Combined Dietary and Exercise Intervention in Pediatric Obesity and Its Impact on Anthropometric Measurements and Blood Lipid Parameters

  2025cites this paper
• Nutritional status and metabolic alterations in patients with ataxia-telangiectasia

  2025cites this paper
• The association of childhood HDL cholesterol with atherosclerotic CVD events in adults: findings from the International Childhood Cardiovascular Cohort Consortium.

  2025cites this paper
• Global trends and hotspots of type 2 diabetes in children and adolescents: A bibliometric study and visualization analysis

  2025cites this paper
• Comparison of lipid profiles in children with cyanotic and acyanotic heart disease

  2025cites this paper
• Childhood HDL-C and Adult ASCVD: Mechanistic Insights and Preventive Implications.

  2025cites this paper
• Waist-to-Height Ratio as a predictor of cardiovascular and metabolic health in a pediatric population

  2025cites this paper
• Lipidomic Signatures in Pediatric Metabolic Disorders

  2025cites this paper
• Dyslipidemia Assessed in Pediatric Patients: Validation of LDL-C Assessed by Friedewald Formula, Direct Assessment, and Sampson–NIH Formula

  2025cites this paper
• 14. Children and Adolescents: Standards of Care in Diabetes-2026.

  2025cites this paper
• Dyslipidemia in children and adolescents with CKD G1-G5, on dialysis and after transplantation: a narrative review of clinical studies and practical guidelines

  2025cites this paper
• Lipid screening for cardiovascular risk in youth: A narrative review of current guidelines and potential use of non-fasting measures.

  2025cites this paper
• Beyond the Guidelines: Perspectives on Management of Pediatric Patients with Hypertriglyceridemia

  2024cites this paper
• Metabolic and other morbid complications in congenital generalized lipodystrophy type 4

  2024cites this paper
• Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.

  2024cites this paper
• 2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents

  2024influential citation
• Prevalence and factors associated with dyslipidemia in children aged 6 to 42 months in a Brazilian capital

  2024cites this paper
• Improved Adherence to Lipid Screening in the Pediatric Cardiology Clinic: A Quality Improvement Project

  2024cites this paper
• Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?

  2024cites this paper
• “I don’t think people should die young”: perspectives of parents with children diagnosed with familial hypercholesterolemia

  2024cites this paper
• The Role of Paraclinical Investigations in Detecting Inflammation in Children and Adolescents with Obesity and Metabolic Syndrome

  2024cites this paper
• Pediatric Lipid Screening Prevalence Using Nationwide Electronic Medical Records

  2024cites this paper
• Abnormal blood pressure and pediatric obesity phenotype: Red flags for clinical practice.

  2024cites this paper
• Primary intestinal lymphangiectasia - A rare cause of growth delay.

  2024cites this paper
• Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.

  2024cites this paper
• Exploring the association between individual, family, and program characteristics and change in health outcomes 12 months after enrollment into the CANadian Pediatric Weight management Registry (CANPWR)

  2024cites this paper
• PFAS exposure is associated with an unfavourable metabolic profile in infants six months of age

  2024cites this paper
• Medication Dosing for Children With Overweight and Obesity.

  2024cites this paper
• 14. Children and Adolescents: Standards of Care in Diabetes-2025.

  2024cites this paper
• Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: a cross-sectional study.

  2024cites this paper
• Outcome and late effects of matched related peripheral-blood stem-cell transplantation in children with severe aplastic anemia

  2024cites this paper
• Exploring the complex dynamics of BMI, age, and physiological indicators in early adolescents

  2024cites this paper
• Longitudinal progression trajectory of estimated glomerular filtration rate in children with chronic kidney disease: results from the KNOW-Ped CKD (KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease)

  2024cites this paper
• Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles.

  2024cites this paper
• Advances in familial hypercholesterolemia.

  2024cites this paper
• Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome

  2024cites this paper
• Obstructive sleep related breathing disorders and cardiometabolic risk factors - A Portuguese birth cohort.

  2024cites this paper
• Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional study.

  2024cites this paper
• Cardiometabolic factors and vitamin D deficiency in pediatric patients with chronic kidney disease

  2024cites this paper
• Comparison of Two Strategies for Hypercholesterolemia Detection through Point-of-Care Testing

  2024cites this paper
• Establishing non-fasting reference values for plasma lipids levels based on age, sex, and puberty stage in a French-Canadian pediatric population

  2024cites this paper
• Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety

  2024cites this paper
• Myopathy in Statin-Treated Children and Adolescents: A Practical Approach

  2024cites this paper
• Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life

  2023cites this paper
• Prevalence of hypercholesterolaemia in outpatient children aged 9–11 years

  2023cites this paper
• Algorithms for Treating Dyslipidemia in Youth

  2023cites this paper
• Determinants of obesity among rural adolescents in Vhembe district, Limpopo Province, South Africa

  2023cites this paper
• Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy

  2023cites this paper
• Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness

  2023cites this paper
• Hepatic fibrosis: a manifestation of the liver disease evolution in patients with Ataxia-telangiectasia

  2023cites this paper
• Estimation of LDL-C using machine learning models and its comparison with directly measured and calculated LDL-C in Turkish pediatric population

  2023cites this paper
• Elevated serum lead and cadmium levels associated with increased risk of dyslipidemia in children aged 6 to 9 years in Shenzhen, China

  2023cites this paper
• Cardiovascular and Diabetes Risk in Preschoolers

  2023cites this paper
• Metabolomics Analysis Reveals Molecular Signatures of Metabolic Complexity in Children with Hypercholesterolemia

  2023cites this paper
• Obesity Management in Children and Adolescents.

  2023cites this paper
• Obesity in Pediatric Congenital Heart Disease: The Role of Age, Complexity, and Sociodemographics

  2023cites this paper
• Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN

  2023cites this paper
• Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?

  2023cites this paper
• Metabolic, inflammatory and adipokine differences on overweight/obese children with and without metabolic syndrome: A cross-sectional study

  2023cites this paper
• [Correlation of uric acid with carotid intima media thickness in obese adolescents].

  2023cites this paper
• Age-, Sex-, and Puberty-Associated Reference Intervals for Lipid Profile in Iranian Children and Adolescents

  2023cites this paper
• Percent body fat, but not body mass index, is associated with cardiometabolic risk factors in children and adolescents

  2023cites this paper
• Pediatric dyslipidemia is associated with increased urinary ACE activity, blood pressure values, and carotidal-femoral pulse wave velocity

  2023cites this paper
• When economy meets physiopathology: A novel cost-effectiveness model finally considers the cumulative effect of LDL cholesterol burden.

  2023cites this paper
• Effects of Body Mass Index Changes In Pediatric Kidney Transplant Patients.

  2023cites this paper
• Isochromosome Xq and the risk of metabolic comorbidities in Turner syndrome.

  2023cites this paper
• Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice

  2023cites this paper
• Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations

  2023cites this paper
• 14. Children and Adolescents: Standards of Care in Diabetes-2024.

  2023cites this paper
• Validation of low-density lipoprotein cholesterol equations in pediatric population

  2023cites this paper
• Hepatic Fibrosis: A Manifestation of the Evolution of Liver Disease in Patients with Ataxia-Telangiectasia

  2022cites this paper
• [Usefulness of a nutritional strategy on dyslipidemia in pediatric patients with terminal chronic kidney disease].

  2022cites this paper
• Heterozygous c.1730G > C (p.Trp577Ser) variation in a case with familial hypercholesterolemia

  2022cites this paper
• Sex-related differences in single nucleotide polymorphisms associated with dyslipidemia in a Korean population

  2022cites this paper
• Percent Body Fat-Related Disparities of Serum Ferritin on the Risk of Lipid Metabolism Abnormalities in Children and Adolescents

  2022cites this paper
• 14. Children and Adolescents: Standards of Care in Diabetes-2023.

  2022cites this paper
• Lipid disorders in children – an underestimated problem

  2022cites this paper
• Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina.

  2022cites this paper
• Factors Associated With Treatment Adherence to a Lifestyle Intervention Program for Children With Obesity: The Experience of a Large Tertiary Care Pediatric Hospital

  2022cites this paper
• Impact of One-Year Dietary Education on Change in Selected Anthropometric and Biochemical Parameters in Children with Excess Body Weight

  2022cites this paper
• On the mechanism of the cholesterol lowering ability of soluble dietary fibers: Interaction of some bile salts with pectin, alginate, and chitosan studied by isothermal titration calorimetry

  2022cites this paper
• The leptin/adiponectin ratio as prognostic marker for dyslipidemia during 1 year of follow-up in pediatric patients receiving kidney replacement therapy.

  2022cites this paper
• Recommendations for overcoming challenges in the diagnosis of lysosomal acid lipase deficiency

  2022cites this paper
• Cardiovascular risk among 6-8-year-old children living in urban and rural communities in Ecuador: A cross-sectional analysis

  2022cites this paper